BioNexus
Latest round
- Seed
Last raised
- Aug 2026
Total raised
- Undisclosed
Investors
- 2
About BioNexus
Based in Suwon, South Korea, and founded in 2024, BioNexus develops AI and bioinformatics solutions for research, diagnostics, and healthcare applications. The company operates its headquarters in Suwon and maintains research facilities in both Suwon and Seoul. According to the company website, BioNexus has expanded through collaborations with universities, government agencies, hospitals, and research institutes, while securing multiple AI and bioinformatics-related projects. The company also established a corporate research institute in 2025 and completed capital increases through new share issuances in 2025. The company focuses on AI-powered bio data analysis and research automation solutions. Its key offerings include Co-Scientist, an AI research assistant platform, and Agentic-RAG, a knowledge retrieval and analysis solution. BioNexus leverages AI, large language models (LLMs), genomics data, and biological big data to support hypothesis generation, research design, biomarker discovery, drug development, and scientific data analysis. The company's revenue is generated by providing AI bioinformatics platforms, research automation solutions, data analysis services, technology development projects, and contract research engagements for government agencies, research institutes, universities, hospitals, and corporate clients. The company website also references multiple awarded projects, research service contracts, and collaborative programs as part of its business activities. Based on the company's most recent activities, BioNexus appears focused on expanding its AI-powered life science research platform, strengthening collaborations with healthcare and biotechnology organizations, and advancing technologies involving multi-agent AI systems, large language models, biomarker discovery, and precision healthcare. The company's stated mission is to reduce the time and cost of life science research through AI and bio data while building a data-driven healthcare platform for healthier and longer lives.
Who invested in BioNexus
2 investors across 1 round
See all investors in BioNexus
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Aug 7, 2026
Amount
Undisclosed
Investors
Questions about BioNexus
Who invested in BioNexus?
BioNexus has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has BioNexus raised?
BioNexus has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did BioNexus last raise money?
BioNexus's most recent round on record is a Seed, in Aug 2026.
What does BioNexus do?
Based in Suwon, South Korea, and founded in 2024, BioNexus develops AI and bioinformatics solutions for research, diagnostics, and healthcare applications.
Where is BioNexus headquartered?
BioNexus is headquartered in Suwon, South Korea.
Which VCs invest in companies like BioNexus?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back healthcare it companies at BioNexus's stage. Their profiles are linked below.
VCs backing healthcare it startups at Seed
Raising like BioNexus? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.